Key Dates
April 14, 2020 - National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional). See NOFO PAR-20-169.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The purpose of this notice is to inform the research community that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) intends to reissue a Notice of Funding Opportunity PAR-20-169 "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)."
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The NOFO is expected to be published in late summer 2023 with an expected application due date in fall 2023.
This NOFO will utilize the P41 activity code. Details of the planned NOFO are provided below.
This Notice encourages investigators with expertise and insights into this area of Biomedical Technology to begin to consider applying for this NOFO.
This NOFO encourages grant applications for NCBIB. NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly.
Direct costs (excluding equipment) are not limited and are expected to vary among applications. Typical direct costs for NCBIB range between $600,000 and $750,000. In addition, up to $500,000 can be requested for special-purpose equipment for the duration of a five-year project period.
Funding Information
TBD
TBD
Direct costs (excluding equipment) are not limited and are expected to vary among applications. Typical direct costs for NCBIB range between $600,000 and $750,000. In addition, up to $500,000 can be requested for special-purpose equipment for the duration of a five-year project period.
TBD
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Behrouz Shabestari, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
301-451-6771
[email protected]